BRICKELL BIOTECH INC (BBI)
US10802T2042 - Common Stock
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -39.87M | -39.47M | -20.91M | -23.88M | -16.25M | |||
| Depreciation Amortization | 29.00K | 22.00K | 10.00K | 30.00K | 150.00K | |||
| Change In Working Capital | -3.88M | -556.00K | -1.65M | -13.63M | 3.16M | |||
| Interest Paid | N/A | N/A | 0.00 | N/A | N/A | |||
| Other non cash items | 3.94M | 3.86M | 2.52M | 1.50M | -1.50M | |||
| OPERATING CASH FLOW | -39.80M | -36.15M | -20.03M | -35.98M | -14.45M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 4.00K | -36.00K | -20.00K | -10.00K | -40.00K | |||
| Other Investing Activity | N/A | 0.00 | 4.50M | 32.52M | 1.32M | |||
| INVESTING CASH FLOW | 4.00K | -36.00K | 4.48M | 32.51M | 1.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 440.00K | 2.59M | N/A | |||
| Stock Issued/Repurchased | 22.40M | 33.00M | 38.00M | 50.00K | 0.00 | |||
| Other Financing Activity | N/A | -51.00K | N/A | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 22.30M | 32.95M | 38.44M | 2.64M | 0.00 | |||
| CHANGE IN CASH | -17.50M | -3.23M | 22.89M | -830.00K | -13.17M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -39.80M | -36.15M | -20.03M | -35.98M | -14.45M | |||
| Capital Expenditure | 4.00K | -36.00K | -20.00K | -10.00K | -40.00K | |||
| FREE CASH FLOW | -39.79M | -36.18M | -20.05M | -35.99M | -14.49M | |||
All data in USD